menu
    • menu

    Company profile for Sirnaomics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sirnaomics is leveraging an unsurpassed level of knowledge and experience in RNA interference (RNAi) technology and forging a path to high value creation with exciting clinical product development programs in multiple therapeutic areas. Sirnaomics, Inc. was established in 2007 by a group of leading scientists from top US pharmaceutical companies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SirnaomicsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    401 Professional Drive, Suite 280 Gaithersburg, MD 20879
    Telephone
    Telephone
    301-740-1730
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sirnaomics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sirnaomics Subscribed For 17,527,696 Subscription Shares
    Sirnaomics Subscribed For 17,527,696 Subscription Shares

    04 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sirnaomics-has-been-subscribed-for-17-527-696-subscription-shares-new-capital-injection-to-promote-business-growth-and-development-302267528.html

    PR NEWSWIRE
    04 Oct 2024
    Share Share
    Sirnaomics Shows Novel MOA Of siRNA For Fat Reduction
    Sirnaomics Shows Novel MOA Of siRNA For Fat Reduction

    19 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sirnaomics-announces-demonstration-of-a-novel-mechanism-of-action-of-its-sirna-therapeutics-for-focal-fat-reduction-in-journal-of-cosmetic-dermatology-302252985.html

    PR NEWSWIRE
    19 Sep 2024
    Share Share
    Sirnaomics Partners With Gore Range Capital For Aesthetic Medicine JV
    Sirnaomics Partners With Gore Range Capital For Aesthetic Medicine JV

    31 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sirnaomics-announces-a-partnership-with-gore-range-capital-for-establishment-of-a-jv-sagesse-bio-to-advance-its-rnai-therapeutics-into-aesthetic-medicine-302211747.html

    PR NEWSWIRE
    31 Jul 2024
    Share Share
    Sirnaomics Completes IND-Enabling Studies For STP125G In Cardiovascular Care
    Sirnaomics Completes IND-Enabling Studies For STP125G In Cardiovascular Care

    11 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sirnaomics-announces-completion-of-ind-enabling-studies-of-safety-and-efficacy-for-stp125g-with-nhp-models-targeting-apoc3-for-treatment-of-cardiovascular-diseases-302195644.html

    PR NEWSWIRE
    11 Jul 2024
    Share Share
    Sirnaomics Completes STP707 Ph I Study With Strong Safety For Pancreatic Cancer
    Sirnaomics Completes STP707 Ph I Study With Strong Safety For Pancreatic Cancer

    28 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sirnaomics-announces-completion-of-stp707-phase-i-clinical-study-with-strong-safety-profile-and-disease-activity-for-the-treatment-of-pancreatic-cancer-patients-302185472.html

    PR NEWSWIRE
    28 Jun 2024
    Share Share
    Sirnaomics Demonstrates Antitumor Activity Of Novel Conjugate
    Sirnaomics Demonstrates Antitumor Activity Of Novel Conjugate

    12 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sirnaomics-demonstrates-strong-antitumor-activity-of-its-novel-oligonucleotide-chemodrug-conjugate-in-journal-of-oncology-research-and-therapy-302171871.html

    PR NEWSWIRE
    12 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search